Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

South Korean (KOSPI) Clinical Research and Equipment Industry Analysis

UpdatedNov 21, 2024
DataAggregated Company Financials
Companies31
  • 7D-2.3%
  • 3M-0.06%
  • 1Y34.0%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 7.6%, driven by a pullback from Samsung BiologicsLtd of 1.3%. On the other hand HLB bioStepLtd is actually up 8.4%. In the past year, the industry has gained 32%. Looking forward, earnings are forecast to grow by 19% annually.

Industry Valuation and Performance

Has the South Korean Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 Nov 2024₩74.8t₩4.8t₩885.3b16x84.5x15.4x
Sat, 19 Oct 2024₩84.8t₩4.8t₩885.3b14.3x95.8x17.5x
Mon, 16 Sep 2024₩77.4t₩4.8t₩885.3b14x87.5x16x
Wed, 14 Aug 2024₩73.9t₩4.5t₩731.7b15.3x101x16.3x
Fri, 12 Jul 2024₩64.7t₩4.5t₩731.7b18.6x88.5x14.3x
Sun, 09 Jun 2024₩59.4t₩4.6t₩689.6b19.2x86.1x12.9x
Tue, 07 May 2024₩60.7t₩4.4t₩635.1b19.8x95.6x13.9x
Thu, 04 Apr 2024₩64.3t₩4.7t₩656.9b18.9x97.9x13.8x
Sat, 02 Mar 2024₩60.7t₩4.5t₩714.4b34.6x85x13.4x
Mon, 29 Jan 2024₩60.8t₩4.5t₩714.4b34.5x85.1x13.4x
Wed, 27 Dec 2023₩57.3t₩4.5t₩721.5b32.7x79.4x12.6x
Fri, 24 Nov 2023₩57.0t₩4.6t₩742.0b22.5x76.9x12.5x
Sun, 22 Oct 2023₩55.3t₩4.4t₩660.9b27.1x83.7x12.6x
Tue, 19 Sep 2023₩58.4t₩4.4t₩660.9b30.1x88.4x13.3x
Thu, 17 Aug 2023₩61.4t₩4.2t₩673.4b28.7x91.1x14.6x
Sat, 15 Jul 2023₩58.0t₩4.2t₩673.4b29.1x86.2x13.8x
Mon, 12 Jun 2023₩62.3t₩4.2t₩666.5b31.4x93.5x14.7x
Wed, 10 May 2023₩61.7t₩4.1t₩626.3b27.6x98.6x15.1x
Fri, 07 Apr 2023₩62.9t₩4.1t₩626.3b29.1x100.4x15.4x
Sun, 05 Mar 2023₩61.6t₩3.5t₩427.8b21.5x144.1x17.7x
Tue, 31 Jan 2023₩62.6t₩3.5t₩426.6b20.2x146.9x18x
Thu, 29 Dec 2022₩64.8t₩3.4t₩428.7b20.6x151.2x18.9x
Sat, 26 Nov 2022₩69.8t₩3.4t₩445.5b21.9x156.6x20.5x
Mon, 24 Oct 2022₩65.6t₩3.0t₩448.5b23.1x146.2x22x
Wed, 21 Sep 2022₩62.7t₩3.0t₩448.5b26.4x139.9x21x
Fri, 19 Aug 2022₩69.0t₩2.7t₩454.7b29.5x151.9x25.4x
Sun, 17 Jul 2022₩64.9t₩2.7t₩454.7b28.7x142.8x23.9x
Tue, 14 Jun 2022₩63.6t₩2.7t₩454.7b25.3x139.8x23.4x
Thu, 12 May 2022₩62.9t₩2.4t₩379.4b22.7x165.7x25.9x
Sat, 09 Apr 2022₩60.2t₩2.4t₩379.4b25x158.8x24.8x
Mon, 07 Mar 2022₩57.8t₩2.4t₩408.2b26x141.7x24.6x
Wed, 02 Feb 2022₩55.6t₩2.3t₩412.7b23.7x134.7x23.7x
Fri, 31 Dec 2021₩67.8t₩2.3t₩412.7b28.3x164.4x28.9x
Sun, 28 Nov 2021₩64.9t₩2.3t₩390.6b26.2x166x28x
Price to Earnings Ratio

166x


Total Market Cap: ₩64.9tTotal Earnings: ₩390.6bTotal Revenue: ₩2.3tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Clinical Research and Equipment Industry Price to Earnings3Y Average 115.9x202220232024
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 83.4x which is lower than its 3-year average PE of 116x.
  • The 3-year average PS ratio of 18.1x is higher than the industry's current PS ratio of 15.2x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have grown 31% per year over the last three years.
  • Revenues for these companies have grown 28% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does South Korean Clinical Research and Equipment compare with similar industries?

KR Market2.33%
Healthcare-1.15%
Life Sciences-2.29%
Clinical Research and Equipment-2.29%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A278650 HLB bioStepLtd₩2.16k8.3%
+₩13.9b		-19.7%PS3.7x
A038290 Macrogen₩16.20k7.9%
+₩11.9b		-25.3%PS1.2x
A216400 Invites Biocore₩7.40k17.5%
+₩8.5b		-21.1%n/a
A359090 C&R Research₩1.12k12.0%
+₩6.8b		-5.9%PE12.3x
A238120 Aligned Genetics₩3.21k12.1%
+₩5.0b		-18.4%PE13.9x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A238120

₩3,205.00

Aligned Genetics

7D

12.1%

1Y

-18.4%

Aligned Genetics, Inc.'s (KOSDAQ:238120) Shareholders Might Be Looking For Exit

Nov 20
Aligned Genetics, Inc.'s (KOSDAQ:238120) Shareholders Might Be Looking For Exit

A347740

₩2,120.00

P&K Skin Research Center

7D

5.2%

1Y

-16.4%

A038290

₩16,200.00

Macrogen

7D

7.9%

1Y

-25.3%

Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement

Nov 13
Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement

A359090

₩1,120.00

C&R Research

7D

12.0%

1Y

-5.9%

A220100

₩15,880.00

FutureChemLtd

7D

-10.6%

1Y

73.0%

More Unpleasant Surprises Could Be In Store For FutureChem Co.,Ltd's (KOSDAQ:220100) Shares After Tumbling 27%

Nov 12
More Unpleasant Surprises Could Be In Store For FutureChem Co.,Ltd's (KOSDAQ:220100) Shares After Tumbling 27%

A207940

₩939,000.00

Samsung BiologicsLtd

7D

-1.9%

1Y

30.2%

Samsung Biologics Co.,Ltd. (KRX:207940) Investors Are Less Pessimistic Than Expected

Nov 11
Samsung Biologics Co.,Ltd. (KRX:207940) Investors Are Less Pessimistic Than Expected

A216400

₩7,400.00

Invites Biocore

7D

17.5%

1Y

-21.1%

A223250

₩3,060.00

DreamCIS

7D

-9.1%

1Y

-10.3%

A141080

₩97,300.00

LigaChem Biosciences

7D

-17.3%

1Y

111.5%

A278650

₩2,160.00

HLB bioStepLtd

7D

8.3%

1Y

-19.7%

Does HLB bioStepLtd (KOSDAQ:278650) Have A Healthy Balance Sheet?

Oct 21
Does HLB bioStepLtd (KOSDAQ:278650) Have A Healthy Balance Sheet?

A445680

₩18,800.00

Curiox Biosystems

7D

-5.1%

1Y

2.5%

A187660

₩3,075.00

Hyundai ADM Bio

7D

-7.2%

1Y

35.8%

Is ADM Korea (KOSDAQ:187660) Using Debt Sensibly?

Sep 02
Is ADM Korea (KOSDAQ:187660) Using Debt Sensibly?

A087010

₩105,200.00

Peptron

7D

-9.0%

1Y

188.2%

Peptron (KOSDAQ:087010) Is Carrying A Fair Bit Of Debt

Jun 10
Peptron (KOSDAQ:087010) Is Carrying A Fair Bit Of Debt

A236340

₩3,500.00

MEDIZEN HUMANCARE

7D

6.1%

1Y

-5.4%

A266470

₩240.00

BioInfra Life Science

7D

9.1%

1Y

-50.0%